Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|December 17, 2015
Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotypeYamicia Connor, Sarah Tekleab, Shyama Nandakumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2010
Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesisRituparna Sinha Roy, Shivani Soni, Rania Harfouche, et al.
Cancer Research|October 15, 2013
Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacyAshish A Kulkarni, Bhaskar Roy, Poornima S Rao, et al.
Science Signaling|August 22, 2019
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug toleranceAaron Goldman, Sachin Khiste, Elizaveta Freinkman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2003
Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulationNicola A Johnson, Shiladitya Sengupta, Samir A Saidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapyVivian K Lee, Taewoo Lee, Amrit Ghosh, et al.
Nature Biomedical Engineering|November 6, 2019
Computationally designed antibody-drug conjugates self-assembled via affinity ligandsNimish Gupta, Aasif Ansari, Gaurao V Dhoke, et al.
Nature Biomedical Engineering|January 5, 2020
Author Correction: Computationally designed antibody-drug conjugates self-assembled via affinity ligandsNimish Gupta, Aasif Ansari, Gaurao V Dhoke, et al.
Nature Nanotechnology|June 12, 2026
Activating a B cell immune response regresses immunologically cold tumoursHeena Aggarwal, Nimish Gupta, Aniruddha Sengupta, et al.
Cancer Research|October 20, 2020
Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast CancerMunisha Smalley, Siva Kumar Natarajan, Jayanta Mondal, et al.
Pageof 12